The ASX has been up 1% higher at 7,721 points.
Invictus Energy (ASX:IVZ) has been among the most watched on HotCopper forums after the company confirmed Musuma-1 as the first high-impact exploration well to be drilled outside the Mukuyu gas-condensate discovery area, targeting a new play type in the Cabora Bassa Basin.
Invictus Energy has been 5.5 cents.
Neuren Pharmaceuticals (ASX:NEU) has also been trending on news the primary endpoints for its Phase 3 pivotal clinical trial of its drug in Phelan-McDermid syndrome have been confirmed in a meeting with the U.S. FDA.
Neuren has been $10.74.
And, finally, Bellevue Gold (ASX:BGL) has revised its full-year production guidance down and scrapped its five-year growth plan after “uncharacteristic geological factors” hindered the gold miner’s output in the March quarter.
The company will also soon be running a $156.5 million placement to provide working capital for a revised mine plan and de-risk its balance sheet.
Bellevue Gold was $1.145 before its trading suspension.
More market news
Kowtow: “Biggest day in financial history” on Trump’s tariffs retreat
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.